Acadian Asset Management LLC Milestone Pharmaceuticals Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$5.13 - $7.37 $28,486 - $40,925
-5,553 Reduced 28.82%
13,717 $84,000
Q1 2022

May 12, 2022
BUY
$4.1 - $8.24 $28,244 - $56,765
6,889 Added 55.64%
19,270 $122,000
Q4 2021

Feb 10, 2022
BUY
$5.47 - $7.13 $26,173 - $34,117
4,785 Added 62.99%
12,381 $79,000
Q3 2021

Nov 12, 2021
SELL
$5.28 - $6.29 $23,617 - $28,135
-4,473 Reduced 37.06%
7,596 $42,000
Q2 2021

Aug 11, 2021
BUY
$5.22 - $6.11 $63,000 - $73,741
12,069 New
12,069 $67,000

Others Institutions Holding MIST

# of Institutions
44
Shares Held
28.6M
Call Options Held
200
Put Options Held
0
View Full List

About Milestone Pharmaceuticals Inc.

MIST Quotes by TradingView
  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.2M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email